CLINICAL_TRIALS
trial_result
· 2013-06-07
Clinical Trial Update: Inner-City Anti-IgE Therapy for Asthma [Phase 4]
Summary
A Phase 4 study of anti-IgE therapy for asthma in inner-city patients has completed, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2013-06-07